PubMed Health⌕ Search

Biomedical subjects

G Blinick

Publications and source records attributed to G Blinick.

At least 19 recordsLinked to original sources

Drug addiction in pregnancy and the neonate.

Drug addiction during pregnancy has been managed in two ways: the detoxification program and the methadone-maintenance treatment program. In the detoxification program, there have been few complications for the mother and child except for low birth weight, meconium-stained amniotic fluid, and an increase in breech presentation. The methadone-maintenance treatment program at this time is the most satisfactory approach to the treatment of heroin addiction. The complications of pregnancy in this program are similar to those of the average obstetric population. Low birth weight at term is still frequent for those on methadone maintenance. The problem of multiple drug abuse, including heroin, cocaine, alcohol, tranquilizers, and amphetamines, requires more attention. The characteristics of the withdrawal syndrome and its treatment in infants are described. Excessive weight loss and irritability are commin in these infants. Of the many drugs available for the treatment of the newborn withdrawal syndrome, diazepam is currently favored. The long-term effects of intrauterine drug exposure, the withdrawal syndrome, and treatment are generally unknown. Schedules for management of adult narcotic, alcohol, and barbiturate abuse and newborn narcotic withdrawal are suggested.

Alcoholic Intoxication↗

Methadone assays in pregnant women and progeny.

Data on the concentration of methadone in maternal plasma and urine of pregnant women on methadone in relationship to levels of amniotic fluid, cord blood, fetal urines, and breast milk are presented. These findings do not demonstrate a simple relationship between methadone levels in the neonate and the intensity of the withdrawal syndrome. The effects of multiple drug abuse and other as yet unknown factors may influence the severity of withdrawal signs in the neonate.

Amniotic Fluid↗

Current status of the second-look operation in ovarian carcinoma.

A second-look operation was performed ten times in 240 patients with advanced carcinoma of the ovary treated initially by surgery and postoperative chemotherapy with triethylenethiophosphoramide. Patients undergoing the second-look operation for carcinoma of the ovary were grouped according to removal or retention of ovaries at initial operation and presence of residual tumor before the second surgery. Those whose retained ovaries were removed after complete tumor disappearance have done well. The second-look operation was of limited use where there was palpable residual tumor. Second-look surgery should be performed for patients with retained ovaries and complete clinical regression of tumor after administration of chemotherapy and in selected patients in whom interval treatment permits surgical clearance of tumor. Reduction of tumor target may warrant a second-look operation before the use of newer antitumor drugs.

Adult↗